Physician profile
Dan Yamini
NPI 1962625111
$10,553.90
in general payments reported to CMS, 2019-2025
13 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,124 · 2020: $1,540 · 2021: $3,499 · 2022: $2,044 · 2023: $1,670 · 2024: $529 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,235 · Food and Beverage: $1,052 · Education: $59.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,234.50 |
| Food and Beverage | $1,052.11 |
| Education | $59.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $6,692.56 | 2019-2023 | |
| Abbvie INC. | $1,644.12 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Kci USA, INC. | $800.00 | 2020 | |
| Tepha INC | $441.80 | 2019-2020 | |
| Merz North America, INC. | $366.70 | 2019-2023 | Xeomin |
| Bard Peripheral Vascular, INC. | $172.38 | 2021 | |
| Apyx Medical Corporation | $137.23 | 2019-2020 | |
| Galderma Laboratories, L.P. | $100.43 | 2019-2023 | |
| Revance Therapeutics, INC. | $78.87 | 2024-2025 | Daxxify, Daxi |
| Motiva USA, LLC | $50.99 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $28.14 | 2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $27.22 | 2019 | |
| Mentor Worldwide LLC | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Yamini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.